Surrogate end points in clinical research: hazardous to your health.
about
Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventionsRamelteon for insomniaHormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2Hormonal contraceptives for contraception in overweight or obese womenSteroidal contraceptives: effect on bone fractures in womenHormonal contraceptives for contraception in overweight or obese womenProgestin-only pills for contraceptionSteroidal contraceptives: effect on bone fractures in womenPsychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventionsHormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2Steroidal contraceptives: effect on bone fractures in womenNonlatex versus latex male condoms for contraceptionOspemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.Live birth is the correct outcome for clinical trials evaluating therapy for the infertile coupleImmunostimulation in the era of the metagenome.Design of cohort studies in chronic diseases using routinely collected databases when a prescription is used as surrogate outcome.The COMET Handbook: version 1.0.Dealing with missing outcomes: lessons from a randomized trial of a prenatal intervention to prevent early childhood cariesGuide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.Cost-effectiveness of blood glucose test strips in the management of adult patients with diabetes mellitus.Test-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests.Methods: the coalition for improving maternity services:.The use and abuse of surrogate endpoints in clinical research in transfusion medicine.Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.Surrogate end points: how well do they represent patient-relevant end points?Putting risk into perspective: the US medical eligibility criteria for contraceptive use.Update on hormonal contraception and bone density.Evidence-based medicine in practice.Climbing for preventing and treating health problems: a systematic review of randomized controlled trials.New frontiers in female contraception (and male condoms): 2012.Prevalence of unwanted pregnancy in Iran: a systematic review and meta-analysis.Transdermal contraception methods: today's patches and new options on the horizon.Metabolic impact of combined hormonal contraceptives containing estradiol.Expedited drug review process: Fast, but flawedStriking balance between expedited review and expecting efficacious anticancer drug and biologics: An ongoing challenge.Scientific Opinion of the PPR Panel on the follow‐up of the findings of the External Scientific Report ‘Literature review of epidemiological studies linking exposure to pesticides and health effects’Selective outcome reporting and sponsorship in randomized controlled trials in IVF and ICSI.Doing it hard in the bush: Aligning what gets measured with what matters.Interstitial lung disease points to consider for clinical trials in systemic sclerosis.Surrogate endpoints in global health research: still searching for killer apps and silver bullets?
P2860
Q24186643-31A607D5-B4C8-4011-989C-0628E7E10BF1Q24198232-A4C36AEB-9D2E-4A40-A2A3-CA48973A8D60Q24199074-0B2B66D7-EAC8-465E-BF61-50043F588639Q24234234-14F7852D-BB17-4700-AFF4-D2F03458C610Q24235567-51EB7795-9846-421C-9B3B-E8649230D151Q24236450-4C022FB7-878D-4F27-B1A6-84881B9A1D6EQ24240459-00ED2A01-A60D-4D75-8C11-C877DE1C9118Q24240975-00345BE6-961D-42E7-86C4-0A97A40ADCC2Q24243097-5433785C-52ED-4F17-BD8F-E0200CBA7BE0Q24243772-1D8009A2-C89B-417A-844F-A54E407B8DD1Q24243923-41BF4EA5-A59E-4E49-8A6C-E43975FE4439Q24244624-498B5D01-6913-486F-A035-65D0ED8D4727Q30491704-E1CF6289-CFA8-4DF4-BA66-FBC45644484AQ33694204-6355DDF4-07CF-4D1D-B55F-D8466971E203Q33827416-607B6771-30DA-4F6A-BB7B-51B3CAB9E872Q33860483-ED66E98F-BB1E-4E91-B502-841833C4063FQ33877196-C388F65D-52F5-43BC-972C-5D0CA556C2BAQ34152806-0A3D8EA7-53B8-4785-A444-EFBAF5B4B3F9Q34165056-D891DC72-9FF3-49A7-9690-1DD86B98CD5AQ36137741-3DA9B00F-FCCB-429C-9883-C4E66F47B8BBQ36290699-586AF9E6-5E16-48FF-9CAD-FCF95C2A0121Q36692977-5050F82E-F684-4C2E-978D-EC570BAA6843Q37174835-488BAC59-7950-47FF-A078-CD1542472DFFQ37458317-9683423B-7A82-400B-A0CD-487F23F31F39Q37755085-AF2787E4-F3E3-421B-948C-377AEFA1E82AQ37871932-F0EA4F12-982A-4EFE-B53C-19D679F35834Q37874152-3FF14161-92F5-485A-B0E4-4EDEDA033ECCQ37874691-4A2CA752-9613-499F-98C0-4A4927EB0399Q37921615-57A8FEE7-AFBC-46C4-80AB-F20D2E2CCF71Q38001737-F4EC2A0D-3A33-4653-A0C0-EA4C89C7B8B0Q38102966-0928D44B-AF3F-469F-97D9-28830EEA1848Q38387662-2FD8DD93-15C5-45F1-AD53-FB5E80B10039Q38836319-371528E7-66D6-4FA8-8EBA-993D90193B3AQ38903956-11AEA4E9-6138-49DC-BF0D-73E84F18A2FBQ47122876-FA5131F3-BFD4-44D4-B06E-81EE7E31E77DQ47160732-741C9EF3-5BFC-4B38-A45B-CB8EE8B7E074Q47940411-D330CDC7-1180-4978-B7CD-6F9633E64CA6Q47987963-14DFF5A4-9EA8-409A-9B1C-D719F979B449Q49384982-1562D8C0-9F98-4A5A-86B2-FA0BB4497EBDQ52614515-8FEC0E3E-B429-47B3-92BB-578DAF5E31BD
P2860
Surrogate end points in clinical research: hazardous to your health.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Surrogate end points in clinical research: hazardous to your health.
@ast
Surrogate end points in clinical research: hazardous to your health.
@en
type
label
Surrogate end points in clinical research: hazardous to your health.
@ast
Surrogate end points in clinical research: hazardous to your health.
@en
prefLabel
Surrogate end points in clinical research: hazardous to your health.
@ast
Surrogate end points in clinical research: hazardous to your health.
@en
P1476
Surrogate end points in clinical research: hazardous to your health.
@en
P2093
Kenneth F Schulz
P304
P356
10.1097/01.AOG.0000157445.67309.19
P407
P433
P50
P577
2005-05-01T00:00:00Z